A recent study by Bao et al. suggested that pancreatic cancer-associated new-onset diabetes (PCAND) is characterized primarily by reduced insulin secretory capacity resulting from β-cell dysfunction10. This evidence concerns the gene INS and familial pancreatic carcinoma.